Form 4: Oscar Health Executive Ranmali Bopitiya Reports Stock Sales to Cover Tax Obligations

Sentiment:

SEC Form 4


Ranmali Bopitiya, EVP & Chief Legal Officer of Oscar Health, Inc., reported the sale of Class A Common Stock to cover tax obligations related to vesting equity awards.

Summary

  • On June 4, 2024, Ranmali Bopitiya, EVP & Chief Legal Officer of Oscar Health, Inc., filed a Form 4 detailing recent transactions in the company's Class A Common Stock.
  • The transactions included the acquisition of shares through the vesting of restricted stock units and the sale of shares to satisfy tax withholding obligations.
  • Bopitiya sold 17,168 shares on June 3, 2024, at an average price of $19.46 and 447 shares on June 4, 2024, at an average price of $19.09.
  • These sales were executed pursuant to a Rule 10b5-1 trading plan established prior to February 27, 2023.
  • Bopitiya also acquired shares through the vesting of restricted stock units on June 1, 2024, in three separate transactions of 20,425, 16,447, and 4,867 shares respectively.
  • Following these transactions, Bopitiya directly owns 137,388 shares of Class A Common Stock and 142,974, 180,922, and 53,537 restricted stock units.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing related to stock transactions by an executive. It doesn't inherently convey positive or negative sentiment.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies. Sales to cover tax obligations related to equity compensation are typical and often pre-planned using Rule 10b5-1 trading plans to avoid accusations of insider trading.

Stakeholder Impact

  • The stock sales could have a minor impact on shareholders due to the increased supply of shares in the market, but the effect is likely minimal given the relatively small volume of shares sold.

Key Dates

DateDescription
January 14, 2022Date of Power of Attorney execution.
June 1, 2022Start date for vesting of 20,425 restricted stock units over four years in 16 equal quarterly installments.
February 27, 2023Date prior to which the Rule 10b5-1 instruction letter was entered into.
June 1, 2023Start date for vesting of 16,447 restricted stock units over four years in 16 equal quarterly installments.
June 1, 2024Vesting date for restricted stock units and acquisition of shares.
June 1, 2024Start date for vesting of 4,867 restricted stock units over three years in 12 equal quarterly installments.
June 3, 2024Sale of 17,168 shares of Class A Common Stock at an average price of $19.46.
June 4, 2024Sale of 447 shares of Class A Common Stock at an average price of $19.09.
June 4, 2024Date of Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.